Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Immunome (IMNM) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Varegacestat Reference Formulation, Varegacestat Test Formulation A, Varegacestat Test Formulation B, Varegacestat Test Formulation CHealthyPhase IRecruitingA Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy ParticipantsMay 20, 2026―
Im-1617Colorectal Cancer, Non-small Cell Lung Cancer, Cancer, Breast Cancer, Esophageal Cancer, Stomach CancerPhase IRecruitingA Phase 1 Study of IM-1617 in Participants With Advanced CancerMay 05, 2026
177Lu-Im-3050Solid MalignanciesPhase IRecruitingA Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced CancerMar 18, 2026
Varegacestat, Moxifloxacin 400 MgHealthy VolunteerPhase ICompletedA Cardiac Liability Study of Varegacestat in Healthy ParticipantsFeb 25, 2025―
VaregacestatHealthy VolunteerPhase ICompletedA Phase 1 Mass Balance Study of VaregacestatFeb 05, 2025―
Im-1021Hematologic Malignancies, Solid MalignanciesPhase IRecruitingA Phase 1 Study of IM-1021 in Participants With Advanced CancerFeb 04, 2025
VaregacestatHealthy Volunteer, Hepatic Impairment (Hi)Phase IActive Not RecruitingA Varegacestat Hepatic Impairment StudyJan 24, 2025―
Varegacestat, ItraconazoleHealthy VolunteerPhase ICompletedA Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy ParticipantsNov 04, 2024―
Al102Desmoid, Desmoid Tumorphase2AndPhase3Active Not RecruitingA Study of AL102 in Patients With Progressing Desmoid TumorsApr 23, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Immunome, Inc. (IMNM) have in its pipeline
Immunome IMNM is currently developing the following drugs: Varegacestat Reference Formulation, Varegacestat Test Formulation A, Varegacestat Test Formulation B, Varegacestat Test Formulation C, Im-1617, 177Lu-Im-3050, Varegacestat, Moxifloxacin 400 Mg, Varegacestat, Im-1021, Varegacestat, Itraconazole, Al102. These drug candidates are in various stages of clinical development as the company works toward FDA approval.